Free Trial

Upexi (NASDAQ:UPXI) Upgraded to Hold at Wall Street Zen

Upexi logo with Business Services background

Upexi (NASDAQ:UPXI - Get Free Report) was upgraded by analysts at Wall Street Zen to a "hold" rating in a research note issued to investors on Friday.

Upexi Trading Up 3.5%

Shares of UPXI stock traded up $0.38 during mid-day trading on Friday, hitting $11.33. 206,446 shares of the stock traded hands, compared to its average volume of 863,105. The stock's fifty day moving average is $7.97 and its two-hundred day moving average is $5.23. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.53 and a current ratio of 0.58. Upexi has a 52-week low of $1.90 and a 52-week high of $22.57.

Upexi (NASDAQ:UPXI - Get Free Report) last released its quarterly earnings results on Friday, May 16th. The company reported ($2.87) EPS for the quarter. The business had revenue of $3.16 million during the quarter.

Insider Activity

In other Upexi news, CFO Andrew James Norstrud purchased 43,860 shares of the firm's stock in a transaction on Thursday, April 17th. The shares were purchased at an average cost of $2.28 per share, with a total value of $100,000.80. Following the purchase, the chief financial officer now owns 59,138 shares in the company, valued at approximately $134,834.64. This represents a 287.08% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Allan Marshall acquired 657,895 shares of the firm's stock in a transaction on Thursday, April 17th. The shares were acquired at an average price of $2.28 per share, with a total value of $1,500,000.60. Following the completion of the purchase, the chief executive officer now owns 809,318 shares of the company's stock, valued at $1,845,245.04. This trade represents a 434.47% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 942,984 shares of company stock valued at $2,150,004 in the last quarter. Insiders own 31.60% of the company's stock.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Upexi stock. Bank of Montreal Can bought a new position in shares of Upexi, Inc. (NASDAQ:UPXI - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 10,008 shares of the company's stock, valued at approximately $36,000. Bank of Montreal Can owned approximately 0.81% of Upexi as of its most recent SEC filing. Hedge funds and other institutional investors own 5.68% of the company's stock.

About Upexi

(Get Free Report)

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.

Read More

Should You Invest $1,000 in Upexi Right Now?

Before you consider Upexi, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Upexi wasn't on the list.

While Upexi currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Next Palantir? AI-Defense Stock Set for Explosive Growth
2 Chip Stocks Are Soaring—But One Could Break Out This Summer
Congress Bought This Stock at the Bottom—Will You Miss It?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines